Navigation Links
Alexza Reports 2012 Second Quarter Financial Results and Provides Business Update
Date:8/8/2012

MOUNTAIN VIEW, Calif., Aug. 8, 2012 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today reported financial results for the fiscal quarter ended June 30, 2012 and provided a business update.  The net loss for the quarters ended June 30, 2012 and 2011, as reported in accordance with accounting principles generally accepted in the United States (GAAP), were $7.0 million and $9.0 million, respectively.  The net loss for the six-month periods ended June 30, 2012 and 2011 were $10.8 million and $17.4 million, respectively.  At June 30, 2012, Alexza had consolidated cash, cash equivalents, marketable securities and restricted cash of $26.4 million.

"Since our last quarterly update in May, we have made strong progress with both of our ADASUVE™ marketing applications, resulting in the resubmission of our ADASUVE NDA and the Day 120 Response for our ADASUVE MAA," said Thomas B. King, President and CEO of Alexza.  "We also completed the EU Pre-Approval Inspection of our Mountain View facility.  We now have our NDA PDUFA date in December 2012 and also project our Day 210 opinion from the CHMP for our MAA in December of this year.

King continued, "We have also established a committed equity financing facility with Azimuth Opportunity, L.P., replacing a similar facility that expired in June.  This new financing facility provides Alexza additional financing flexibility by giving us the potential ability to raise capital efficiently."

Alexza Business Update

The following key events, in chronological order, occurred since the beginning of the second quarter of 2012:

  • In May, Alexza received a second Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding its ADASUVE New Drug Application (NDA).  In June, Alexza resubmitted its ADASUVE NDA to the FDA in response
    '/>"/>

  • SOURCE Alexza Pharmaceuticals, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. Alexza Announces Management Promotions
    2. Alexza Secures a $20 Million Committed Equity Financing Facility with Azimuth Opportunity, L.P.
    3. Alexza Announces Reverse Stock Split in Order to Maintain NASDAQ Listing
    4. Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Alexza Pharmaceuticals Inc.
    5. Alexza Receives Complete Response Letter for Adasuve™ NDA
    6. Alexza to Announce 2012 First Quarter Financial Results on Thursday, May 10, 2012
    7. NxStage Reports Record Revenue For The Second Quarter Of Fiscal 2012
    8. InfuSystem Holdings, Inc. Reports $14.1 Million of Revenues for the Second Quarter of 2012; Announces Annualized Cost Savings in Excess of $1 million
    9. diaDexus, Inc. Reports Second Quarter 2012 Financial Results
    10. HeartWare Reports Second Quarter 2012 Results
    11. Omeros Corporation Reports Second Quarter 2012 Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/30/2014)... , July 30, 2014  El Camino Hospital, ... patient care, is utilizing the Leaf Patient Monitoring system ... position and movement of patients susceptible to bed sores. ... six month-long, 138-patient study of the system, which showed ... protocols. Turning patients regularly is the one of the ...
    (Date:7/30/2014)... 2014 Research and Markets has ... Aseptic Packaging Industry Report 2014" report to their ... The Global and Chinese Aseptic Packaging Industry Report ... state of the global Aseptic Packaging industry with a ... a basic overview of the industry including definitions, classifications, ...
    (Date:7/30/2014)... 2014 Reportlinker.com announces that a new ... mHealth and Home Monitoring – 6th ... Executive summary mHealth can revolutionize ... outcomes, decreased costs and improved sustainability of the ... still in an early stage, but on the ...
    Breaking Medicine Technology:El Camino Hospital Utilizes Cutting-Edge Leaf Patient Monitor System to Help Reduce Risk of Pressure Ulcers 2El Camino Hospital Utilizes Cutting-Edge Leaf Patient Monitor System to Help Reduce Risk of Pressure Ulcers 3Global and Chinese Aseptic Packaging Industry Report 2014 2mHealth and Home Monitoring - 6th Edition 2mHealth and Home Monitoring - 6th Edition 3mHealth and Home Monitoring - 6th Edition 4mHealth and Home Monitoring - 6th Edition 5mHealth and Home Monitoring - 6th Edition 6mHealth and Home Monitoring - 6th Edition 7mHealth and Home Monitoring - 6th Edition 8mHealth and Home Monitoring - 6th Edition 9mHealth and Home Monitoring - 6th Edition 10mHealth and Home Monitoring - 6th Edition 11
    ... YORK, Sept. 15, 2011 Close to 100 openly HIV-positive ... around the world have signed a new letter ( http://tinyurl.com/pozPrEPletter ... than on fear or misinformation," of the challenges and opportunities ... and bisexual men and transgender women. The new open letter ...
    ... Qualitest Pharmaceuticals today issued a voluntary, nationwide, retail-level ... is being implemented because of a packaging error, where ... reversing the weekly tablet orientation and making the lot ... error and the potential for this error to have ...
    Cached Medicine Technology:Open Letter From HIV-Positive Prevention Advocates Rejects Misinformation About Pre-Exposure Prophylaxis (PrEP) 2Open Letter From HIV-Positive Prevention Advocates Rejects Misinformation About Pre-Exposure Prophylaxis (PrEP) 3Qualitest Pharmaceuticals Issues a Nationwide Voluntary Recall of Oral Contraceptives 2
    (Date:7/30/2014)... 30, 2014 Decene is an ... chain of ten carbon atoms with one double ... of 1-decenes. It can be used as a ... to produce epoxides, amines, oxo alcohols, synthetic lubricants, ... Early buyers will receive 10% customization on this ...
    (Date:7/30/2014)... Washington, D.C. (PRWEB) July 30, 2014 ... Community Anti-Drug Coalitions of America (CADCA) , the ... statement in response to the New York Times ... published on Sunday, July 27th. , “CADCA is ... their very public call for national marijuana legalization. The ...
    (Date:7/30/2014)... Washington, DC (PRWEB) July 30, 2014 ... have recently joined the Board of Directors of ... provides guidance for the Association, which has a ... in healthcare delivery through telecommunications and information technology. ... members of the Association, possess extraordinary expertise and ...
    (Date:7/30/2014)... WEDNESDAY, July 30, 2014 (HealthDay News) -- Medical costs ... States are more than $32 billion each year, according ... Control and Prevention. The yearly financial toll of ... to reach an estimated $49 billion by 2020. ... for COPD, which provide state public health practitioners with ...
    (Date:7/30/2014)... whether a person is at risk for suicide could lie ... Chemical changes to a gene involved in the brain,s response ... the study,s authors explained. Spotting those changes in a blood ... suicide, they said. "Suicide is a major preventable public ... efforts because we have no consistent way to predict those ...
    Breaking Medicine News(10 mins):Health News:Europe 1-decene Market is Expected to Reach 251.7 thousand MT in 2018 - New Report by MicroMarket Monitor 2Health News:Europe 1-decene Market is Expected to Reach 251.7 thousand MT in 2018 - New Report by MicroMarket Monitor 3Health News:Europe 1-decene Market is Expected to Reach 251.7 thousand MT in 2018 - New Report by MicroMarket Monitor 4Health News:CADCA Responds to New York Times Editorial Board's Call for Marijuana Legalization 2Health News:American Telemedicine Association Welcomes Two New Members to the Board of Directors 2Health News:Annual COPD Costs To Hit $49 Billion by 2020: CDC 2Health News:Could a Blood Test Predict Suicide Risk? 2Health News:Could a Blood Test Predict Suicide Risk? 3
    ... , , , ... month that the first recipients enrolled in Medicare. Now is the time ... for all," said Dr. Jane L. Delgado, President and CEO of the National ... , , "President Obama set out in his ...
    ... Evidence That Criticisms Are Registering As Debate Intensifies , ... Congress works through specific health reform proposals, the July Kaiser Health Tracking Poll ... reform now, though there is some softening of support as criticisms and doubts ... been the case over the past ten months, a majority of the American ...
    ... 28th Annual KLOS Blood Drive Aims ... LOS ANGELES, July 22 The American Red Cross and 95.5 KLOS ... Blood Drive. The 2009 KLOS Blood Drive will run for five days, ... and classic rock fans are encouraged to donate at any of the 19 ...
    ... , INCLINE VILLAGE, Nev., July 22 PDL BioPharma, ... hold a conference call and webcast on Thursday, July 30 at 4:30 p.m. ... and provide a business update. The call and webcast will follow the release ... , , Conference Call Details , ...
    ... shows devices contain carcinogens, other toxins , WEDNESDAY, ... cigarettes, known as e-cigarettes, has shown that they ... compound used in antifreeze, U.S. health officials said ... cartridges filled with nicotine, flavorings and other chemicals. ...
    ... WASHINGTON, July 22 There are many provisions in ... care greatly about the freedom to choose their health care. Some of ... * Eliminates Existing Private Insurance Coverage (i.e., Eliminates Your Choice ... But Is Just Fine With You and Your Family) , ...
    Cached Medicine News:Health News:Time to Get the Job Done Says Alliance President and CEO 2Health News:Majority of Public Maintains Support for Addressing Health Care Reform Now 2Health News:Majority of Public Maintains Support for Addressing Health Care Reform Now 3Health News:Majority of Public Maintains Support for Addressing Health Care Reform Now 4Health News:Majority of Public Maintains Support for Addressing Health Care Reform Now 5Health News:KLOS & Red Cross Set to Rock SoCal With Massive 5 Day Blood Drive 2Health News:KLOS & Red Cross Set to Rock SoCal With Massive 5 Day Blood Drive 3Health News:PDL BioPharma to Announce Second Quarter 2009 Financial Results and Hold Conference Call July 30, 2009 2Health News:E-Cigarettes Pose a Health Hazard, FDA Warns 2Health News:E-Cigarettes Pose a Health Hazard, FDA Warns 3Health News:Mandate for Health Insurance: Inconvenient Truths About How It Will Affect You and Your Family 2
    ... COMBO 2 Assay is a second generation ... capture for in vitro qualitative detection and ... The assay uses a family of Gen-Probe's ... Amplification (TMA) and Dual Kinetic Assay (DKA). ...
    ... is a novel device for the ... gonorrhoeae and Neisseria meningitidis. This ... and is easily transportable as a ... incubate and examine the growth of ...
    ... NearVision™ CK is the only procedure designed for ... and +3.00 D or presbyopic patients who would ... D and 2.25 D to achieve a myopic ... in their non-dominant eye to temporarily improve near ...
    ... The CC-7000 is a mid range space ... take a non-contact picture of the corneal endothelium ... the corneal thickness in the central area. The ... 9" monitor, which is supplied with the system., ...
    Medicine Products: